Scholars Central

EditorialPublished 2013

Challenges for HIV/AIDS Therapy

Authors: Da-Yong Lu, Ting-Ren Lu, Hong-Ying Wu, Jing-Yu Che

Advances in Pharmacoepidemiology and Drug Safety

Volume 2 · Issue 4 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

AIDS (acquired immune deficient syndrome) is a human infectious disease. AIDS patients, if not be treated, commonly suffer a gradual loss of human immune-defensive functions and finally die of infectious complications within 2 years after AIDS symptoms occur in patients. AIDS patients can be treated with a series of anti-viral drugs to decrease the virus-load and slow the pace of deadest symptoms of AIDS and prolong life-spans of patients by high active anti-retroviral therapy (HAART). Even though HAART is very effective, HIV/AIDS patients can not be cured by HAART. And there are a lot of drawbacks in this therapy. Many new ways have been designed for HIV/AIDS therapy. In this editorial, we will address these challenges and treatment options to possible cure all HIV/AIDS patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Advances in Pharmacoepidemiology and Drug Safety.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAdvances in Pharmacoepidemiology and Drug Safety
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Da-Yong Lu”
  • BylineArticles whose byline prints “Ting-Ren Lu”
  • BylineArticles whose byline prints “Hong-Ying Wu”
  • BylineArticles whose byline prints “Jing-Yu Che”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels